Ballast Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
2,238
-116
-5% -$55.7K 0.27% 49
2026
Q1
$1.16M Sell
2,354
-13
-0.5% -$7.05K 0.34% 42
2025
Q4
$1.37M Buy
2,367
+28
+1% +$15.8K 0.38% 39
2025
Q3
$1.13M Buy
2,339
+102
+5% +$47.5K 0.31% 48
2025
Q2
$907K Buy
2,237
+143
+7% +$59.8K 0.27% 52
2025
Q1
$1.04M Buy
2,094
+171
+9% +$92.6K 0.33% 49
2024
Q4
$1M Buy
1,923
+182
+10% +$100K 0.31% 47
2024
Q3
$1.08M Buy
1,741
+25
+1% +$14.8K 0.33% 46
2024
Q2
$949K Buy
1,716
+62
+4% +$35.5K 0.3% 48
2024
Q1
$961K Buy
1,654
+123
+8% +$69K 0.32% 45
2023
Q4
$813K Buy
1,531
+558
+57% +$270K 0.3% 46
2023
Q3
$493K Buy
+973
New +$518K 0.2% 66

Other funds holding TMO

Ballast Advisors's TMO Position: Q2 2026 in Review

Ballast Advisors reduced its Thermo Fisher Scientific (TMO) stake by 4.9% in Q2 2026, selling an estimated $55.7K and leaving 2,238 shares worth $1.12M. The position accounts for 0.27% of the portfolio, ranked #49.

Ballast Advisors first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.37M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ballast Advisors held 2,238 shares of Thermo Fisher Scientific worth $1.12M as of Q2 2026.
  • Ballast Advisors sold 116 Thermo Fisher Scientific shares in Q2 2026, an estimated $55.7K.
  • Thermo Fisher Scientific made up 0.27% of Ballast Advisors's portfolio in Q2 2026, its #49 holding.
  • Ballast Advisors first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Ballast Advisors's Thermo Fisher Scientific position peaked at $1.37M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ballast Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.